Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AMRX - Amneal wins approval for generic TobraDex


AMRX - Amneal wins approval for generic TobraDex

RealPeopleGroup/E+ via Getty Images The FDA has approved an ANDA from Amneal Pharmaceuticals ([[AMRX]] +0.2%) for a generic of TobraDex (dexamethasone and tobramycin ophthalmic suspension).The drug is indicated for for steroid-responsive inflammatory ocular conditions.Sales of TobraDex for the 12 months ended May 2021 were ~$118M, according to IQVIA.

For further details see:

Amneal wins approval for generic TobraDex
Stock Information

Company Name: Amneal Pharmaceuticals Inc. Class A
Stock Symbol: AMRX
Market: NASDAQ
Website: amneal.com

Menu

AMRX AMRX Quote AMRX Short AMRX News AMRX Articles AMRX Message Board
Get AMRX Alerts

News, Short Squeeze, Breakout and More Instantly...